151 related articles for article (PubMed ID: 17671111)
21. Inhibition of angiogenesis and invasion in malignant gliomas.
Chi A; Norden AD; Wen PY
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
[TBL] [Abstract][Full Text] [Related]
22. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.
Sogno I; Vannini N; Lorusso G; Cammarota R; Noonan DM; Generoso L; Sporn MB; Albini A
Recent Results Cancer Res; 2009; 181():209-12. PubMed ID: 19213570
[TBL] [Abstract][Full Text] [Related]
23. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives.
Bisacchi D; Benelli R; Vanzetto C; Ferrari N; Tosetti F; Albini A
Cancer Detect Prev; 2003; 27(3):229-38. PubMed ID: 12787731
[TBL] [Abstract][Full Text] [Related]
24. Angiogenesis inhibitors: from laboratory to clinical application.
Nakamura T; Matsumoto K
Biochem Biophys Res Commun; 2005 Jul; 333(2):289-91. PubMed ID: 15953588
[No Abstract] [Full Text] [Related]
25. The interaction of radiation therapy and antiangiogenic therapy.
O'Reilly MS
Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
[TBL] [Abstract][Full Text] [Related]
26. American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancer.
Duda DG
IDrugs; 2007 Jun; 10(6):366-9. PubMed ID: 17641996
[No Abstract] [Full Text] [Related]
27. Molecular and cellular biomarkers for angiogenesis in clinical oncology.
Bertolini F; Mancuso P; Shaked Y; Kerbel RS
Drug Discov Today; 2007 Oct; 12(19-20):806-12. PubMed ID: 17933680
[TBL] [Abstract][Full Text] [Related]
28. [A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].
Qiu H; Wang GM
Ai Zheng; 2007 Dec; 26(12):1392-6. PubMed ID: 18076810
[TBL] [Abstract][Full Text] [Related]
29. Antiangiogenics and radiotherapy.
Shannon AM; Williams KJ
J Pharm Pharmacol; 2008 Aug; 60(8):1029-36. PubMed ID: 18644195
[TBL] [Abstract][Full Text] [Related]
30. Selective targeting of the tumour vasculature.
Chan LS; Daruwalla J; Christophi C
ANZ J Surg; 2008 Nov; 78(11):955-67. PubMed ID: 18959693
[TBL] [Abstract][Full Text] [Related]
31. The Mediterranean Diet, a Rich Source of Angiopreventive Compounds in Cancer.
Martínez-Poveda B; Torres-Vargas JA; Ocaña MDC; García-Caballero M; Medina MÁ; Quesada AR
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480406
[TBL] [Abstract][Full Text] [Related]
32. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
33. Tumoral angiogenesis: review of the literature.
Khosravi Shahi P; Fernández Pineda I
Cancer Invest; 2008 Feb; 26(1):104-8. PubMed ID: 18181052
[TBL] [Abstract][Full Text] [Related]
34. Novel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesis.
La DS; Belzile J; Bready JV; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn JC; Flynn SR; Graceffa RF; Harriman SP; Larrow JF; Long AM; Martin MW; Morrison MJ; Patel VF; Roveto PM; Wang L; Weiss MM; Whittington DA; Teffera Y; Zhao Z; Polverino AJ; Harmange JC
J Med Chem; 2008 Mar; 51(6):1695-705. PubMed ID: 18311900
[TBL] [Abstract][Full Text] [Related]
35. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
Cohen-Jonathan Moyal E
Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
[TBL] [Abstract][Full Text] [Related]
36. Thyroid cancer molecular signaling pathways and use of targeted therapy.
Kundra P; Burman KD
Endocrinol Metab Clin North Am; 2007 Sep; 36(3):839-53, viii. PubMed ID: 17673131
[TBL] [Abstract][Full Text] [Related]
37. From the Guest Editor: Monoclonal antibodies have emerged as versatile and useful cancer therapeutics.
Weiner LM
Cancer J; 2008; 14(3):147-8. PubMed ID: 18536553
[No Abstract] [Full Text] [Related]
38. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
39. Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications.
Tortora G; Ciardiello F; Gasparini G
Nat Clin Pract Oncol; 2008 Sep; 5(9):521-30. PubMed ID: 18594498
[TBL] [Abstract][Full Text] [Related]
40. A novel role for a familiar protein in apoptosis induced by proteasome inhibition.
McConkey DJ
Cancer Cell; 2008 Jul; 14(1):1-2. PubMed ID: 18598936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
